REFERENCES
- Lake C. R., Gallant S., Masson E., Miller P. Adverse Drug Effects Attributed to Phenylpropanolamine: A Review of 142 Case Reports. Am. J. Med. 1990; 89: 195–208
- Fein F. S., Factor S. M., Cho S., Miller-Green B., Carroll D. W., Sonnenblick E. H. Catecholamine-Induced Myocardial Necrosis in Experimental Diabetes Mellitus. Arch. Pathol. Lab. Med. 1983; 107: 480–483
- Simoes M. V., Maciel B. C., Marin-Neto J. A. Reversible Segmental Left Ventricular Dysfunction Caused by Accidental Administration of Sympathomimetic Drug in Humans. Int. J. Cardiol. 1997; 61: 93–96
- Simons M., Downing S. E. Coronary Vasoconstriction and Catecholamine Cardiomyopathy. Am. Heart J. 1985; 109: 297–304
- Vatner S. F., Higgins C. B., Braunwald E. Effects of Norepinephrine on Coronary Circulation and Left Ventricular Dynamics in the Conscious Dog. Circ. Res. 1974; 34: 812–823
- Chappel C. J., Rona G., Balazs T., Baudry R. Comparison of Cardiotoxic Actions of Certain Sympathomimetic Amines. Can. J. Biochem. Physiol 1959; 37: 35–42
- Downing S. E., Lee J. C. Contribution of α-Adrenoceptor Activation to the Pathogenesis of Norepinephrine Cardiomyopathy. Circ. Res. 1983; 52: 471–478
- Leo P. J., Hollander J. E., Shih R. D., Marcus S. M. Phenylpropanolamine and Associated Myocardial Injury. Ann. Emerg. Med. 1996; 28: 359–362
- Pentel P. R., Jentzen J., Sievert J. Myocardial Necrosis Due to Intraperitoneal Administration of Phenylpropanolamine in Rats. Fundam. Appl. Toxicol. 1987; 9: 167–172
- Pentel P. R., Mikell F. L., Zavoral J. H. Myocardial Injury After Phenylpropanolamine Ingestion. Br. Heart J. 1982; 47: 51–54
- Rosenblum I., Wohl A., Stein A. A. Studies in Cardiac Necrosis. I. Production of Cardiac Lesions with Sympathomimetic Amines. Toxicol. Appl. Pharm. 1965; 7: 1–8
- Van Vliet P. D., Burchell H. B., Titus J. L. Focal Myocarditis Associated with Pheochromocytoma. N. Engl. J. Med. 1966; 274: 1102–1108
- Oosterbaan R., Burns M. J. Myocardial Infarction Associated with Phenylpropanolamine. J. Emerg. Med. 2000; 18: 55–59
- Call T. D., Hartneck J., Dickinson W. A., Hartman C. W., Bartel A. G. Acute Cardiomyopathy Secondary to Intravenous Amphetamine Abuse. Ann. Intern. Med. 1982; 97: 559–560
- O'Neill M. E., Arnolda L. F., Coles D. M., Nikolic G. Acute Amphetamine Cardiomyopathy in a Drug Addict. Clin. Cardiol. 1983; 6: 189–191
- Horowitz J. D., Lang W. J., Howes L. G., Christophidis N., Fennessy M. R., Rand M. J., Louis W. J. Hypertensive Responses Induced by Phenylpropanolamine in Anorectic and Decongestant Preparations. Lancet 1980; 1: 60–61
- Hyams J. S., Leichtner A. M., Breiner R. G., Hill D. W., McComb R. B., Manger W. M. Pseudopheochromocytoma and Cardiac Arrest Associated with Phenylpropanolamine. JAMA 1985; 253: 1609–1610
- Wolfgang M., Duvernoy C. Positive Phentolamine Test in Hypertension Induced by a Nasal Decongestant. N. Engl. J. Med. 1969; 280: 877
- Hollander J. E. The Management of Cocaine-Associated Myocardial Ischemia. N. Engl. J. Med. 1995; 333: 1267–1272
- Lange R. A., Cigarroa R. G., Yancy C. W., Jr., Willard J. E., Popma J. J., Sills M. N., McBride W., Kim A. S., Hillis L. D. Cocaine-Induced Coronary Artery Vasoconstriction. N. Engl. J. Med. 1989; 321: 1557–1562
- The Laboratory Rat: Biology and Diseases, H. J. Baker, J. R. Lindsey, S. H. Weisbroth. Academic Press Inc., New York 1979; 1